Google
Trusted Resources: News & Events
Latest announcements and gatherings
Quest Diagnostics Launches Genetic Test to Assess Risk for Sickle Cell Anemia, Other Inherited Disorders
Couples who wish to know the risk of passing on a genetic disease such as sickle cell anemia to their children may now do so with QHerit, a new screening test by Quest Diagnostics.
The QHerit Pan-Ethnic Expanded Carrier Screen test covers 22 genetic diseases and was produced based on screening guidelines issued in March 2017 by the American College of Gynecology (ACOG). The test determines the likelihood of a couple passing on a heritable disorder to their children and its impact.
The test is able to predict the occurrence of diseases such as sickle cell anemia, cystic fibrosis, thalassemia, Joubert Syndrome 2, Tay-Sachs disease, and Fragile X syndrome, among others.
+myBinderRelated Content
-
Hydroxyurea to Lower Transcranial Doppler Velocities and Prevent Primary Stroke: The Uganda NOHARM Sickle Cell Anemi...In sub-Saharan Africa, sickle cell anemi...
-
Transcranial Doppler screening for stroke risk in children with sickle cell disease: a systematic reviewBackground Sickle cell disease (SCD) is ...
-
Ghana Launches Partnership With Novartis to Improve Diagnosis and Treatment of People With Sickle Cell DiseaseThe Government of Ghana announced a new ...
-
Discovery could help treatments for sickle cell diseaseResearch team establishes biomarkers for...
-
Inexpensive sickle cell diagnostic tool shows perfect accuracy in UgandaAn inexpensive, easy-to-use diagnostic t...
-
Researchers Develop Test for SCA to be Used in Low-Resource SettingsResearchers have developed an accurate, ...
-
Sickle cell trait may confound blood sugar readings among African-AmericansA new study in JAMA provides evidence th...
To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences. More Information
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.
Powered by
Support for this site is provided by
This platform is made possible through a partnership with the Sickle Cell Disease Association of America, Inc. (SCDAA) and its member organizations. SCDAA's mission is to advocate for people affected by sickle cell conditions and empower community-based organizations to maximize quality of life and raise public consciousness while advancing the search for a universal cure.